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ABSTRACT
Objective: The objective of this study was to synthesize phenylcinnamamide (substituted acetanilide chalcone) derivatives linked to aspirin and 
ibuprofen with potential antibacterial and antifungal activity.
Methods: Substituted acetanilide compounds were reacted with different arylaldehydes through Claisen-Schmidt condensation in the presence of 
KOH. They formed differently substituted acetanilide chalcones (1a-e) which are linked to aspirin and ibuprofen through an ester linkage to form 
compounds (2a-j) using ethyl chloroformate (ECF) as a catalyst.
Results: The synthesized compounds have been characterized by elemental analysis, Fourier transform infrared and1H-nuclear magnetic resonance 
spectroscopy. An antibacterial evaluation was achieved for Gram-positive bacteria (Staphylococcus aureus) and Gram-negative bacteria (Escherichia 
coli) and antifungal for Candida albicans.
Conclusion: Compounds (2a-j) have shown intermediate antimicrobial activity against different strains of microorganisms.
Keywords: Acetanilide, Claisen-Schmidt condensation, Chalcones, Aspirin, Ibuprofen, Antibacterial, Antifungal.
INTRODUCTION
Antimicrobial drugs are compounds which antagonize the survival or 
growth of a variety of microorganisms such as bacteria, viruses, fungi, 
and parasite [1]. Benzalacetophenone (or benzylidene acetophenone) is 
the central core for a variety of important biological compounds which 
known as a group (chalcones or chalconoids). Chalcone is a captivating 
moiety which consists of two aromatic rings linked by enone bridge 
(or α,β-unsaturated ketone) and it belongs to flavonoid family [2]. 
The existence of conjugated chromophore (-CO-CH=CH-) and other 
auxochromes have made them colored compounds [3]. C-H·π (arene) 
hydrogen bonds along the c axis give the molecule a zigzag shape [4]. The 
synthesis and biodynamic activities of chalcones were the cornerstones 
of many kinds of scientific researches around the world [5]. They 
could be prepared synthetically or naturally (like another flavonoid 
family) from plants [6]. Several methods have been described for the 
chemical synthesis of chalcones such as Claisen-Schmidt, Knoevenagel 
condensations and the Meyer-Schuster rearrangement [7-9]. The 
conjugated ketoethylenic bridge has an important role in the behavior 
of chalcone moiety due to the delocalization of π electrons between 
two benzene rings through a bridge which gives it a flexibility in 
electrons movement during reactions [10], consequently it serves as 
starting materials for many heterocyclic compounds and therapeutic 
substances which are used for healing of a lot of illnesses [11]. Chalcones 
show diversity of pharmacological activities such as anticancer [12], 
cytotoxic [13], antibacterial [14], antiviral [15,16], and antifungal [17,18].
Nonsteroidal anti-inflammatory drugs (NSAIDs) are popular non-
opiate compounds used worldwide for the treatment of pain, fever, and 
inflammation [19]. Their mechanism of action involves interfering with 
the cyclooxygenase (COX) pathway, which includes the conversion of 
arachidonic acid by the enzyme COX to prostaglandins [20]. Ibuprofen 
is a chiral molecule which is a derivative of phenyl propionic acid, while, 
aspirin is a salicylate derivative [21]. Various studies have shown potential 
antibacterial and antifungal activities in aspirin and ibuprofen [22,23].
Based on these observations, an attempt was considered to link aspirin 
or ibuprofen to differently substituted acetanilide chalcones that may 
afford a synergistic effect with potential antimicrobial activity. These 
novel conjugates would be prepared by cross-linking of these molecules 
through an ester bond.
METHODS
Acetanilide, benzaldehyde, p-chlorobenzaldehyde, p-nitrobenzaldehyde, 
vanillin, and p-hydroxybenzaldehyde were purchased from Hi-Media 
(India). Acetaminophen, ibuprofen, aspirin, ampicillin, and ketoconazole 
were donated thankfully by The State Company for Drug Industries 
(SDI, Samara, Iraq). Melting points were determined (uncorrected) 
using electrical melting point apparatus, Electrothermal 9300, USA. The 
infrared spectra were performed in KBr disc in the range of 400–4000 
cm−1 by Fourier transform-infrared (FTIR) spectrophotometer/Biotech 
engineering management Co. Ltd (UK). 1H-nuclear magnetic resonance 
(NMR) spectra were recorded using NMR Bruker 500 MHz - Avance III 
and chemical shifts were recorded in parts per million (ppm) downfield 
using tetramethylsilane as an internal reference. Furthermore, 
elemental microanalyses (CHN) were performed by EuroVector EA 3000 
A, Italy, and the percentage of elements was found to be close to that 
of the calculated values. Physical and spectral data of the synthesized 
compounds are recorded in Table 1.
Chemical syntheses
The synthesis of target compounds (1a-e and 2a-j) was achieved, as 
illustrated in Schemes 1 and 2.
Chemical synthesis of compounds 1a-e [24]
Equimolar quantities (0.01 mol) of substituted acetanilide compound 
and aryl aldehyde were dissolved in minimum volume of ethanol 
followed by the addition of KOH solution (40%) slowly over 10 min 
with stirring for 4 h and kept overnight. The reaction mixture was 
evaporated and acidified with cold 10% HCl and washed with cold 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Table 1: Physical and spectral data of the titled compounds
M.F: C15H13NO2, M.Wt: 239.27, m.p: 184–186°C, yield: 81%, elemental analysis: C-72.1%, H-5.3%, and N-5.95%. 
1HNMR (ppm): 9.23 (s, 1H, -NH-C=O), 6.55–7.65 (m, 9H, aromatic), 9.67 (s, 1H,-OH), 7–7.65 (d, 2H, CH=CH=C = O). IR (cm−1): 
3130 (OH), 1640 (C=O), 1605 (C=C) trans-alkene, 3300 (-NH)
M.F: C16H15NO3, M.wt: 369.3, m.p: 201–203°C, yield: 84%, elemental analysis: C-73.66%, H-5.45%, N-5.64%. 1HNMR (ppm): 
9.23, (s, 1H, -NH-C=O), 6.8–7.55 (m, 8H, aromatic), 9.5 (s, 1H,-OH), 7.05–7.36 (d, 2H, CH=CH=C = O), 3.82 (s, 
3H, -OCH3). IR (cm−1): 3125 (-OH), 1635 (C=O), 1600 (C=C) trans-alkene, 3295 (NH), 1090 (C-O-C), 2950, 2870 (C-H) 
asymmetrical (asym.) and symmetrical (sym.) stretching vibration of -CH3 group
M.F: C15H13NO2, M.wt: 239.27, m.p: 179–181°C, yield: 79%, elemental analysis: C-71.9%, H-5.34%, N-6.25%. 1HNMR (ppm): 
9.23(s, 1H, -NH-C=O), 6.76–7.6 (m, 9H, aromatic), 9.46 (s, 1H,-OH), 7.1–7.52 (d, 2H, CH=CH=C = O). IR (cm−1): 3135 (-OH), 
1635 (C=O), 1603 (C=C) trans-alkene, 3290 (NH)
M.F: C15H12N2O4, M.wt: 284.27, m.p: 225–227°C, yield: 72%, elemental analysis: C-60.2%, H-4.59%, N-10.38%. 
1HNMR (ppm): 9.23 (s, 1H, -NH-C=O), 8.37 (d, 2H, aromatic, ortho to NO2), 8.07 (d, 2H, aromatic, meta to NO2), 6.75 (d, 
2H, aromatic, ortho to OH), 7.4 (d, 2H, aromatic, meta to OH), 9.44 (s, 1H,-OH), 7.34,7.75 (d, 1H, α and β H, respectively). 
IR (cm−1): 3100 (-OH), 1630 (C=O), 1595 (C=C) trans-alkene, 3295 (NH), 1550 (N-O) asym. stretching, 1342 (N-O) sym. 
stretching
M.F: C15H12ClNO2, M.wt: 273.72, m.p: 201–203°C, yield: 72%, elemental analysis: C-66.95%, H-4.25%, N-5.88%. 
1HNMR (ppm): 9.23 (s, 1H, -NH-C=O), 7.63n (d, 2H, aromatic, ortho to Cl), 7.7 (d, 2H, aromatic, meta to Cl), 6.75 (d, 2H, 
aromatic, ortho to OH), 7.38 (d, 2H, aromatic, meta to OH), 9.44 (s, 1H,-OH), 7.05,7.62 (d, 1H, α and β H, respectively). 
IR (cm−1): 3095 (-OH), 1620 (C=O), 1590 (C=C) trans-alkene, 3295 (NH) (C=O), 1600 (C=C) trans-alkene, 1080 
aromatic (C-Cl) stretching vibration
M.F: C24H19NO5, M.wt: 401.42, m.p: 137–139°C, yield: 63%, elemental analysis: C-74.07%, H-4.54%, N-3.68%. 1HNMR (ppm): 
9.22 (s, 1H, -NH-C=O), 7.33–8.25 (m, 13H, aromatic), 7.05–7.52 (d, 2H, CH=CH=C = O), 2.4 (s, 3H, -CH3). IR (cm−1): 3028 (-CH 
of alkene), 1748 (C=O of acetic ester), 1727 (C=O of benzoic ester), 1622 (C=O of amide), 1600 (C=C) trans-alkene, 
3300 (NH), 2940, 2865 (C-H) asym. and sym. stretching vibration of -CH3 group
M.F: C24H18N2O7, M.wt: 446.42, m.p: 153–155°C, yield: 65%, elemental analysis: C-66.97%, H-4.33%, N-6.71%. 
1HNMR (ppm): 9.22 (s, 1H, -NH-C=O), 7.3–8.4 (m, 12H, aromatic), 7.35–7.75 (d, 2H, CH=CH=C = O), 2.38 (s, 3H, -CH3). 
IR (cm−1): 3025 (-CH of alkene), 1750 (C=O of acetic ester), 1728 (C=O of benzoic ester), 1620 (C=O of amide), 1590 (C=C) 
trans-alkene, 3300 (NH), 1548 (N-O) asym. stretching, 1340 (N-O) sym. stretching
M.F: C24H18ClNO5, M.wt: 435.86, m.p: 145–147°C, yield: 67%, elemental analysis: C-63.21%, H-4.43%, N-3.39%. 
1HNMR (ppm): 9.21 (s, 1H, -NH-C=O), 7.26–8.21 (m, 12H, aromatic), 7.1–7.6 (d, 2H, CH=CH=C = O), 2.37 (s, 3H, -CH3). 
IR (cm−1): 3030 (-CH of alkene), 1751 (C=O of acetic ester), 1730 (C=O of benzoic ester), 1626 (C=O of amide), 1601 (C=C) 
trans-alkene, 3290 (NH), 1078 aromatic (C-Cl) stretching vibration
M.F: C28H29NO3, M.wt: 427.54, m.p: 105–107°C, yield: 71%, elemental analysis: C-74.92%, H-7.11%, N-3.4%. 1HNMR (ppm): 
9.22(s, 1H, -NH-C=O), 7.1–7.7(m, 13H, aromatic), 7.1–7.5 (d, 2H, CH=CH=C = O), 3.71 (q, 1H, -CH2), 1.6 (d, 3H, -CH3 3), 
2.45 (d, 2H, -CH2 1’), 1.8 (m, 1H, -CH2’), 0.8 (d, 6H, -CH3’). IR (cm−1): 3040 (-CH of alkene), 1758 (C=O of propanoic ester), 
1622 (C=O of amide), 1604 (C=C) trans-alkene, 3295 (NH), 1380 and 1367 (d, C-H bending of isopropyl group), 2965, 
2890 (C-H) asym. and sym. stretching vibration of (-CH3) group
M.F: C28H28N2O5, M.wt: 472.54, m.p: 121–123°C, yield: 73%, elemental analysis: C-74.92%, H-5.61%, N-6.2%. 1HNMR (ppm): 
9.22 (s, 1H, -NH-C=O), 7.12–8.39 (m, 12H, aromatic), 7.35–7.76 (d, 2H, CH=CH=C = O), 3.7 (q, 1H, -CH2), 1.58 (d, 3H, -CH3 3), 
2.43 (d, 2H, -CH2 1’), 1.82 (m, 1H, -CH2’), 0.88 (d, 6H, -CH3’). IR (cm−1): 3036 (-CH of alkene), 1758 (C=O of propanoic ester), 
1625 (C=O of amide), 1602 (C=C) trans-alkene, 3290 (NH), 1382 and 1367 (d, C-H bending of isopropyl group), 2960, 
2885 (C-H) asym. and sym. stretching vibration of -CH3 group, 1550 (N-O) asym. stretching, 1340 (N-O) sym. stretching
M.F: C28H28ClNO3, M.wt: 461.99, m.p: 112–114°C, yield: 71%, elemental analysis: C-75.95%, H-5.81%, N-3.2%. 
1HNMR (ppm): 9.22 (s, 1H, -NH-C=O), 7.12–7.7 (m, 12H, aromatic), 7.05–7.62 (d, 2H, CH=CH=C = O), 3.71 (q, 1H, -CH2), 
1.58 (d, 3H, -CH3 3), 2.43 (d, 2H, -CH2 1’), 1.82 (m, 1H, -CH2’), 0.88 (d, 6H, -CH3’). IR (cm−1): 3045 (-CH of alkene), 1761 (C=O 
of propanoic ester), 1622 (C=O of amide), 1600 (C=C) trans-alkene, 3300 (NH), 1380 and 1365 (d, C-H bending of isopropyl 
group), 2950, 2875 (C-H) asym. and sym. stretching vibration of -CH3 group, 1080 aromatic (C-Cl) stretching vibration
M.F: C24H19NO5, M.wt: 401.42, m.p: 138–140°C, yield: 66%, elemental analysis: C-67.98%, H-4.93%, N-3.65%. 1HNMR (ppm): 
9.22 (s, 1H, -NH-C=O), 7.05–8.25 (m, 13H, aromatic), 7.05–7.62 (d, 2H, CH=CH=C = O), 2.39 (s, 3H, -CH3). IR (cm−1): 
3030 (-CH of alkene), 1748 (C=O of acetic ester), 1725 (C=O of benzoic ester), 1622 (C=O of amide), 1600 (C=C) 
trans-alkene, 3300 (NH), 2940, 2865 (C-H) asym. and sym. stretching vibration of -CH3 group
M.F: C25H21NO6, M.wt: 431.44, m.p: 149–151°C, yield: 69%, elemental analysis: C-67.02%, H-5.11%, N-3.45%. 1HNMR (ppm): 
9.22 (s, 1H, -NH-C=O), 7.05–8.25 (m, 13H, aromatic), 7.05–7.38 (d, 2H, CH=CH=C = O), 2.39 (s, 3H, C=OCH3), 3.87 (s, 3H, 
OCH3). IR (cm−1): 3030 (-CH of alkene), 1748 (C=O of acetic ester), 1725 (C=O of benzoic ester), 1622 (C=O of amide), 
1600 (C=C) trans-alkene, 3300 (NH), 1090 (C-O-C), 2957, 2868 (C-H) asym. and sym. stretching vibration of -CH3 group
M.F: C28H29NO3, M.wt: 427.54, m.p: 106–108°C, yield: 79%, elemental analysis: C-77.98%, H-6.92%, N-3.39%. 1HNMR (ppm): 
9.22 (s, 1H, -NH-C=O), 7.07–7.56 (m, 13H, aromatic), 7.05–7.62 (d, 2H, CH=CH=C = O), 3.71 (q, 1H, -CH2), 1.58 (d, 
3H, -CH3 3), 2.43 (d, 2H, -CH2 1’), 1.82 (m, 1H, -CH2’), 0.87 (d, 6H, -CH3’). IR (cm−1): 3040 (-CH of alkene), 1762 (C=O of 
ester), 1620 (C=O of amide), 1598 (C=C) trans-alkene, 3300 (NH), 1384 and 1371 (d, C-H bending of isopropyl group), 
2950, 2870 (C-H) asym. and sym. stretching vibration of -CH3 group
M.F: C29H31NO4, M.wt: 457.57, m.p: 117–119°C, yield: 81%, elemental analysis: C-77.88%, H-6.72%, N-3.21%. 1HNMR (ppm): 
9.22 (s, 1H, -NH-C=O), 7.07–7.56 (m, 12H, aromatic), 7.05–7.37 (d, 2H, CH=CH=C = O), 3.71 (q, 1H, -CH2), 1.58 (d, 3H, -CH3 3), 
2.43 (d, 2H, -CH2 1’), 1.82 (m, 1H, -CH2’), 0.87 (d, 6H, -CH3’), 3.87 (s, 3H, OCH3). IR (cm−1): 3040 (-CH of alkene), 1762 (C=O of 
ester), 1620 (C=O of amide), 1598 (C=C) trans-alkene, 3300 (NH), 1380 and 1370 (d, C-H bending of isopropyl group), 2962, 
2845 (C-H) asym. and sym. stretching vibration of -CH3 group, 1088 (C-O-C)
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distilled water to obtain compounds 1a-e. These compounds were 
recrystallized from ethanol.
Chemical synthesis of compounds 2a-j [25,26]
The synthesis of these compounds was achieved by reacting compounds 
1a-e by mixed anhydride method with either ibuprofen or aspirin using 
ECFasa catalyst, as shown in Scheme 2.
NSAID (either aspirin or ibuprofen) (0.01 mol) was dissolved in 30 mL 
of dry tetrahydrofuran (THF) containing triethylamine (0.01 mol) and 
placed in a refrigerator at −5 to −10°C. A solution of ECF (0.01 mol) 
was added dropwise to the above mixture over a period of 10 min with 
continuous stirring, which maintained for further 30 min. Compound 
1a-e (0.01 mol) was dissolved in 30 mL THF previously cooled to 0°C 
and was added dropwise over 10 min to the above mixture with stirring 
for 4 h. The solvent was then evaporated, and the resultant precipitate 
was washed with cold NaOH solution (5%) and distilled water.
In vitro antimicrobial screening
The synthesized compounds were evaluated for their antimicrobial 
activity using cup plate method for a zone of inhibition against 
Staphylococcus aureus, Escherichia coli, and Candida albicans [27,28]. 
Compounds (2a-j) and standard drugs (ampicillin and ketoconazole) 
were screened at a concentration of 200 µg/mL; additionally, dimethyl 
sulfoxide was used as a control. In this procedure, melted agar was 
poured into a sterile Petri dish and inoculated with the microorganisms. 
Using a sterile cork borer, wells (8 mm) were made on the surface of an 
agar plate and a specific volume of the screened substances is poured 
in them, plates were incubated at a temperature of 37°C for 48 h. The 
diameter of this zone (mm) was measured and shown in Table 2.
RESULTS AND DISCUSSION
Physical data, including molecular formula (M.F), molecular weights 
(M.wt), melting points (m.p), and spectral data along with antimicrobial 
activity, are shown in Tables 1 and 2, respectively. The chemical structures 
of the synthesized compounds were confirmed by spectrophotometric 
analysis (FTIR, 1HNMR, and elemental analysis). The most significant 
characteristic IR bands that confirm the formation of compounds (1a-e) 
are the appearance of C=C stretching band around 1600 cm−1, shift in 
C=O stretching band to a lower wave number because of the conjugation 
with aromatic double bond, the disappearance of symmetrical and 
asymmetrical stretching bands of substituted acetanilide (CH3) group, 
and the appearance of other bands regarding each compound (such 
as OH stretching for compound 1b at 3125 cm−1) as shown in Table 1. 
Compounds (2a-j) are characterized by the appearance of new ester 
band which is affected by the conjugation with one or both sides. 
The change in chemical shifts, proton counting, integration, and spin-
spin splitting was distinguishable feature in1HNMR, particularly the 
appearance of vinylic (C=C) protons at 7–7.8 (ppm) downfield (because 
of delocalization of π electrons which results in deshielding of these 
protons along with the inductive effect of the neighboring C=O group) 
and disappearance of OH protons due to ester formation [29].
The synthesized compounds were screened against bacterial and 
fungal strains. Compound 2c has the higher zone of inhibition for E. coli 
(19 mm) and C. albicans (18 mm) and compound 2a has the higher zone 
of inhibition for S. aureus (18 mm). The higher activity of compound 2c 
may be attributed to its higher lipophilicity among the aspirin linked 
N-phenylcinnamamide derivatives which may result in higher penetration 
through the microbial cell wall. Compounds (2f, 2i), (2d, 2e, 2j), and 2j 
show no activity on S. aureus, E. coli, and C. albicans, respectively. This 
could be explained by the bulkiness offered by the linking compounds 1a-e 
to ibuprofen which has a great effect on the penetration and consequently 
the activity of compounds 2d, 2e, 2f, 2i, and 2j.
CONCLUSION
Compounds (2a-j) were successfully synthesized, confirmed (by 
elemental analysis, FTIR, and1HNMR), and assessed for their 
antimicrobial activity. Regardless of the potential antimicrobial activity 
of the parent compounds (chalcones, aspirin, and ibuprofen), the 
synergism has not been achieved.
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Scheme 1: Chemical synthesis of compounds 1a-e
Scheme 2: Chemical synthesis of compounds 2a-j
Table 2: Antimicrobial activity of compounds (2a-j) by cup plate 
method
Compound (200 µg/mL) Zone of inhibition
S. aureus E. coli C. albicans
2a 18 16 10
2b 17 15 12
2c 16 19 18
2d 13 --- 5
2e 15 --- 6
2f --- 12 9
2g 15 18 12
2h 16 14 9
2i --- 11 5
2j 12 --- ---
Ampicillin 20 21 ---
Ketoconazole --- --- 20
Solvent control (DMSO) --- --- ---
---: Inactive. Results represent the average of triplicate experiments. 
S. aureus: Staphylococcus aureus, E. coli: Escherichia coli, C. albicans: Candida 
albicans
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